Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 814 results for "Treatment For Multiple Sclerosis"

Genzyme to resubmit Lemtrada NDA for FDA review07-04-2014
Pharma Letter

Sanofi to resubmit Lemtrada sBLA for US FDA's review for treat...

Health care company Sanofi (EURONEXT:SAN)(NYSE:SNY) reported on Monday its plans to resubmit its supplemental Biologics License Application (sBLA) seeking approval of Lemtrada (alemtuzumab) for the treatment of relapsing forms of multiple sclerosis ..., 1 week ago

75 images for Treatment For Multiple Sclerosis

PrimaryCare Today, 2 months ago
Malay Mail, 4 days ago, 2 weeks ago
Pharma Times, 1 week ago
Medical Xpress, 4 weeks ago
Clinical and Experimental Neuroimmunology, 1 month ago
Laboratory Equipment, 2 weeks ago
Daily News, 2 months ago
MedIndia, 3 months ago
Med India, 3 weeks ago

Surveyed U.S. Neurologists Would be Willing to Accept a Novel Primary-Progressive Multiple Sclerosis Therapy with Safety Risk if Proven Effective on Disability Progression

/PRNewswire/ -- Decision Resources Group (DRG) finds that, for the treatment of primary-progressive multiple sclerosis (PP-MS), surveyed U.S. neurologists would be willing to accept a certain level of risk for a therapy with proven efficacy on ...
 BusinessWeek1 week ago Survey: U.S. Neurologists Willing to Accept Safety Risk if New MS Therapies Can Reduce Disability Progression  PT Community1 week ago
Boston Globe

Genzyme to resubmit bid for MS drug approval

Nearly four months after the Food and Drug Administration rejected a multiple sclerosis drug developed by Genzyme, citing the clinical trial's design and a risk of serious side effects, the Cambridge biotech said Monday that it will resubmit an ...
 Boston Globe1 week ago Genzyme to reapply for MS drug approval  WBJournal.com1 week ago Genzyme plans to resubmit MS drug candidate to the FDA  Boston Globe1 week ago
Money Control

US Patents rejects Teva's plea on Copaxone

Hyderabad-based Natco markets Copaxone (Glatiramer Acetate) -- used in the treatment of relapsing-remitting multiple sclerosis -- in the US market. HYDERABAD: The United States Patent and Trademark Office has rejected multi-national drugmaker Teva ...
 Economic Times1 week ago US Supreme Court agrees to hear Tevas pharma's appeal  Money Control2 weeks ago

Statins may slow untreatable, progressive stage of multiple sclerosis

Researchers have suggested that simvastatin, a cheap cholesterol lowering drug, might be a potential treatment option for the secondary progressive, or chronic, stage of multiple sclerosis (MS), which is currently untreatable. Findings from the MS-STAT trial ...
 Business Standard4 weeks ago
Pharma Times

Hepatitis C drug spend to soar 1,800% by 2016

Expensive treatments for rheumatoid arthritis, multiple sclerosis, cancer and, most strikingly, hepatitis C are pushing up costs to an unsustainable level. That is the key conclusion of the latest drug trend report from Express Scripts, the USA's ...
 Pharma Times1 week ago Hepatitis C drug spend to soar 1800 by 2016  Big News Network1 week ago

SLU researcher receives $608,376 grant to design better clinical treatments for multiple sclerosis

Saint Louis University researcher Daniel Hawiger, M.D., Ph.D., has been awarded $608,376 from the National Multiple Sclerosis Society to gain a better understanding of how the autoimmune process that causes multiple sclerosis (MS) may be stopped or ...
 News-Medical.Net1 week ago Saint Louis University receives $600,000 to study immune attacks gone awry  EurekAlert!1 week ago
EMax Health

Classification of Multiple Sclerosis

Downlad PDF Classification of MS The sub-types of MS include: Relapsing-Remitting MS (RRMS) 85% of patients who develop MS have RRMS Severity varies greatly in from individual to individual. Initial average annual relapse rate ...
 Irish Medical Times1 week ago Diagnosing Clinically Isolated Syndrome and MS  EMax Health1 week ago JC Virus Infection Linked to Natalizumab Treatment in Patients With MS  Med India3 weeks ago

Data from University of Basel Hospital Provide New Insights into Multiple Sclerosis

By a News Reporter-Staff News Editor at Clinical Trials Week Data detailed on Autoimmune Diseases and Disorders have been presented. According to news reporting from Basel, Switzerland, by NewsRx journalists, research stated, "Teriflunomide is an ...
 Pharmacy Choice1 week ago Findings from University Hospital Has Provided New Data on Multiple Sclerosis  Pharmacy Choice1 week ago Genzyme's Lemtrada? Approved in Brazil for Treatment of Multiple Sclerosis  Pharmacy Choice1 week ago Genzyme's Lemtrada Approved in Brazil for Treatment of Multiple Sclerosis  4 Traders2 weeks ago

Use of modified cells for the treatment of multiple sclerosis

The present invention describes blood cells chemically coupled with immunodominant myelin peptides and their use in the treatment of Multiple Sclerosis. Description of the Invention SEQUENCE LISTING The instant application contains a Sequence ...
 PharmCast2 weeks ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less